688026.SH
洁特生物
SSE · Healthcare · Medical - Instruments & Supplies · CN
CNY 15.54
−5.65%Year over year
Reported trailing growth
- Revenue
- -6.2%
- EBITDA
- —
- EBIT
- -63.6%
- EPS
- -68.0%
- Free cash flow
- +222.8%
- Operating cash flow
- +160.1%
Forward estimates
Based on analyst estimates
- Revenue
- -19.7%
- EBITDA
- —
- EPS
- —
Three-year CAGR
- Revenue
- -2.6%
- EBITDA
- -8.1%
- EBIT
- -13.4%
- Net income
- -18.1%
- EPS
- -17.8%
- Free cash flow
- +219.4%
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Mar 1, 2026